Clinical Trial Update: Romosozumab Versus Denosumab for Osteoporosis in Long-term Glucocorticoid Users [Phase 4]

View source ↗

Summary

Phase 4 head-to-head trial comparing romosozumab to denosumab in long-term glucocorticoid users with osteoporosis has completed. No results are provided in the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucocorticoid-induced Osteoporosis

Drugs mentioned

• Evenity (romosozumab)
• Prolia (denosumab)

Snippet

Sponsor: Tuen Mun Hospital | Conditions: Glucocorticoid-induced Osteoporosis | Phase 4 | Status: COMPLETED